Back to Search Start Over

CLL-492 Real-World Adherence to First-Line Ibrutinib and Acalabrutinib Single-Agent Among Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Authors :
Xiaoxiao Lu
Bruno Emond
Zaina Qureshi
Jinghua He
Yi Qian
Qing Huang
Patrick Lefebvre
Marie-Hélène Lafeuille
Ryan Jacobs
Source :
Clinical Lymphoma Myeloma and Leukemia. 22:S280-S281
Publication Year :
2022
Publisher :
Elsevier BV, 2022.

Subjects

Subjects :
Cancer Research
Oncology
Hematology

Details

ISSN :
21522650
Volume :
22
Database :
OpenAIRE
Journal :
Clinical Lymphoma Myeloma and Leukemia
Accession number :
edsair.doi...........393df40ba50809340c6e41e82dac2c1b
Full Text :
https://doi.org/10.1016/s2152-2650(22)01350-7
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details